Accelerated Phase Chronic Myeloid Leukemia
Oncology
Prevalence
12.0 / 100K
Incidence
1.9 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Accelerated Phase Chronic Myeloid Leukemia?
There are 1 clinical trial targeting Accelerated Phase Chronic Myeloid Leukemia tracked by BioSniper.
What is the prevalence of Accelerated Phase Chronic Myeloid Leukemia?
The estimated prevalence of Accelerated Phase Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.
Deep-dive into Accelerated Phase Chronic Myeloid Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis